Companies Profiled in the Report
Bausch Health Companies Inc.
Cipla Limited
Crescita Therapeutics Inc.
Galderma
GlaxoSmithKline plc
Glenmark Pharmaceuticals
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson Services, Inc.
LEO Pharma A/S
Merck & Co
Mylan N.V.
Novartis AG

List of Other Notable Players Mentioned in the Report
Abingworth
Acorn Campus Ventures
Adaptimmune
AFA Försäkring
AGF Private Equity
AgonOx
Agreen Biotech
Aju IB Investment
Alaska Permanent Fund
Alexandria Ventures
Allos Therapeutics
Altor BioScience
Amgen
Applied Immune Technologies
Aquilo Capital Management
ARCH Venture Partners
Artax Biopharma
AstraZeneca
Atara Biotherapeutics
Atlas Venture
Autolus (spin off from UCL)
AVG Ventures
Banca Esperia
BankInvest Biomedical Venture
Bayer
Baylor College of Medicine
Bellicum Pharmaceuticals
Bezos Expeditions
Biogen
BioNTech
Biotecnol
bluebird bio
Bpifrance
Brace Pharma Capital
Bristol-Myers Squibb
Broad Institute
Broadfin Capital
Cabaret Biotech
California Institute for Regenerative Medicine
California Institute of Technology
California Stem Cell Agency
Cancer Prevention and Research Institute of Texas
Caribou Sciences
CARsgen
Casdin Capital
Catalyst
Celdara
Celgene
Cell Therapy Catapult
Cellectis
CELLforCURE
Cellular Biomedicine Group
Cellular Therapeutics
Celyad
Children with Leukaemia
Chinese PLA General Hospital
City of Hope Medical Center
CLL Global Research Foundation Alliance
Cold Genesys
Conkwest
Cowen Investment
CRISPR Therapeutics
CrunchFund
Cyto Pulse
Dartmouth College
Deerfield Partners
Dendreon Corporation
Deutsche Krebshilfe
Duke University
Easton Capital
EcoR1 Capital
Editas Medicine
Edmond Venture Capital
Ehime University
Eisai
Eli Lilly
Endocyte
Erasmus University
Eureka Therapeutics
Fate Therapeutics
Felicis Ventures
Fidelity Biosciences
Fiverings Co.
Flagship Ventures
Forbion Capital Partners
Foresite Capital
Formula Pharmaceuticals
Fred Hutchinson Cancer Research Center
Fujita Health University
GammaCell Biotechnologies
Genentech
Genzyme (Sanofi)
Genzyme Ventures
Gilead Sciences
GlaxoSmithKline
Google Ventures
Griffin Securities
H. Lee Moffitt Cancer Center and Research Institute
Harbinger Venture Capital
Harvard University
Healthcare investment company Syncona
Heat Biologics
Herlev Hospital
High Line Venture Partners
ImmunoCellular Therapeutics
Immunocore
Imperial Innovations
IMS Health Capital
Innovative Genome Initiative
Intellia Therapeutics
Intrexon
Iowa State University
Jannsen Biotech
Jennison Associates
Jichi Medical University
JMP Securities
John Hopkins University
John Wayne Cancer Institute
Jonsson Comprehensive Cancer Center
JP Moulton Charitable Foundation
Juno Therapeutics
Karolinska University Hospital
Keio University, School of Medicine
Khosla Ventures
Kite Pharma
Leiden University Medical Center
Leukemia and Lymphoma Society
Ligand Pharmaceuticals
Lion Biotechnologies
Lonza Biologics
Loyola University
M.D. Anderson Cancer Center
Massachusetts Institute of Technology
MaxCyte
Mayo Clinic
Medigene
Memorial Sloan Kettering Cancer Center
Merck Serono
Mie University
Millennium Pharmaceuticals
MolMed
Monash University
Morphotek
Mustang Therapeutics
Nagoya University
Nantes University Hospital
Nantworks
National Cancer Institute
National Institute of Health
National University of Singapore
NeoStem
New Enterprise Associates (NEA)
New Leaf Venture
Novartis Institute for Biomedical Research (NIBR)
Novo A/S
Oberland Capital Healthcare
ODYSSEE Venture
Ohio University
Omega Funds
Oncodesign Biotechnology
OnCyte
Ono Pharmaceutical Co.
Onyx Pharmaceuticals
Opexa Therapeutics
Opus Bio
OrbiMed Advisors
Oxford BioMedica
Partners Innovation Fund
Pasteur Institute
Peking University
Perceptive Advisors
Peter MacCallum Cancer Centre, University of Melbourne
Pfizer
Pharmacyclics
Polaris Partners
Pontifax
Precision Biosciences/Pregenen
Precision Genome Engineering
Progenitor Cell Therapy
Pure MHC
QueensBridge Venture Partners
Quogue Capital
QVT Financial
RA capital Management
Ramius Capital Group
Redmile Group
Remeditex Ventures
Renji Hospital
Ridgeway Capital Partners
Riverbank Capital Securities
Roche
Rock Spring Capital
Roswell Park Cancer Institute
Sabby Capital
San Raffaele Hospital (OSR)
Sanderling Ventures
Sangamo Biosciences
Sanofi-Genzyme BioVentures
Seattle Children's Hospital
Seattle Genetics
Sectoral Asset Management
Servier
Shanghai Cancer Institute
Sheba Medical Center
Shenzhen Second People's Hospital
Shionogi
Silicon Valley Bank
Sorrento Therapeutics
Southwest Hospital
Spectrum Pharmaceuticals
SR One
St. Jude Children’s Research Hospital
Stage Cell Therapeutics
Statcom Co.
Suma Ventures
Sun Yat-Sen University
Sunol Molecular Corporation
SV Angel
Swedish Cancer Society
T. Rowe Price Associates
Takara Bio
T-Cell Factory
Tel Aviv Sourasky Medical Centre
TETHYS
Texas Children's Hospital
The Children's Hospital of Philadelphia
The Christie NHS Foundation Trust
The Methodist Hospital System
The Netherlands Cancer Institute
Theravectys
Thermo Fisher Scientific
Third Rock Ventures
Three Arch Opportunity Fund
TILT Biotherapeutics
TNK Therapeutics (wholly owned subsidiary of Sorrento Therapeutics)
Transposagen Biopharmaceuticals
TVM Capital
Two Blades Foundation
TxCell
University College of London
University Health Network
University of California
University of Connecticut
University of Florida
University of Milano-Bicocca
University of Minnesota
University of Oxford
Perelman School of Medicine, University of Pennsylvania
University of Southern California
University of Zurich
Unum Therapeutics
Uppsala University
Valeant Pharmaceuticals
venBio
Venrock
Versant Ventures
Viking Global Investors
Weill Cornell Medical College
Weizmann Institute of Science
Wellington Management
X-Body
Y Combinator
Yuan Capital
ZIOPHARM Oncology
 
List of Organizations Mentioned in the Report
ACRF Centre for Advanced Drug Delivery Technologies
American Cancer Society (ACS)
Agencia Nacional de Vigiloncia Sanitaria (ANVISA)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center of Excellence in Immunology (CEI)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services programs
European Medicines Agency (EMA)
European Union
Experimental Transplantation & Immunotherapy Branch at CCR
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
International Agency for Research on Cancer (IARC)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Laboratory of Tumor Immunology and Biology at CCR
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare (MHLW)
National Cancer Institute (NCI)
National Cancer Institute's Center for Cancer Research (CCR)
National Development and Reform Commission (NDRC)
National Institutes of Health (NIH)
NCBI
NCI's Division of Cancer Biology's Cancer Immunology, Hematology, and Etiology Branch (CIHEB)
The Therapeutic Goods Administration
United Nations (UN)
University of Connecticut
World Population Prospects
World Health Organization (WHO)